Organization and Business Overview (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Feb. 19, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Oct. 24, 2025 |
Oct. 20, 2025 |
Jul. 02, 2025 |
Jun. 16, 2025 |
|
| Preferred stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | |||||
| Net cash outflows from operations | $ 13,361 | $ 10,270 | ||||||
| Accumulated Deficit | 127,945 | 117,409 | ||||||
| Cash and cash equivalents | 6,392 | $ 5,905 | ||||||
| Private Placement [Member] | ||||||||
| Private placement | $ 8,000 | 10,900 | ||||||
| Milestone payment | $ 1,000 | |||||||
| Investor [Member] | ||||||||
| Investment | $ 11,000 | |||||||
| Investment | $ 8,500 | |||||||
| Remaining investment | $ 2,500 | |||||||
| Series D Convertible Preferred Stock [Member] | ||||||||
| Preferred stock, par value | $ 0.001 | |||||||
| Biofrontera Group [Member] | Series D Convertible Preferred Stock [Member] | ||||||||
| Shares issued | 3,019 | 3,019 | ||||||
| Preferred stock, par value | $ 0.001 | |||||||
| X | ||||||||||
- Definition Remaining investment. No definition available.
|
| X | ||||||||||
- Definition Sales milestone payments amount. No definition available.
|
| X | ||||||||||
- Definition Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of investments transferred from the entity's investments in noncash transactions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|